London, 6-7 July 2011: Social Media in the Pharmaceutical Industry

Healthcare Engagement Strategy e-journal is proud to have been selected as a media partner for the Social Media in the Pharmaceutical Industry Conference, which takes place July 6-7, 2011 in London, United Kingdom.

Here’s what the organizers are saying about the event:

The potential of social media as a tool to increase awareness in healthcare issues has become the ‘hot’ subject in pharmaceutical communications over the past 12 months. However, one of the issues still unclear to many is whether it is possible to accurately gauge the success of social media activity and how this can be done.

Alex Butler, EMEA Marketing Communications Manager, Johnson and Johnson Pharmaceuticals, one of the world’s thought-leaders in the area of social media communications is clear about the answer to this question. In a recent article on the ‘pharmaphorum’ website, he explains that:

‘Actually the problem for those of us who are passionate about digital communication generally and social media specifically is that there are too many measures. For social media I could list literally 100 things that could be measured… The trick is understanding your objectives and applying metrics accordingly. This is bespoke for every company and every campaign, simple as that…If this {the campaign} is promotional in nature then a direct link to the bottom line is appropriate. If this is about improving trust, raising awareness or improving the quality of life for people with a particular condition we can measure this. In essence as a business we have always been concerned with understanding whether the actions we take are successful. Social media can help you do this in a way we have not been able to before.’
Hear more from Alex and other leaders in pharmaceutical communications including:

  • Andrew Widger, Director, Media Relations, EMEA, Pfizer
  • Tim Lloyd, Deputy Head of Publishing & eCommunications, Department of Health, UK
  • Marc Monseau, Director, Corporate Communications and Social Media, Johnson & Johnson
  • John Vieira, Senior Director, Marketing Operations & Strategic Services, Daiichi Sankyo
  • Cressida Robson, Director, European Communications, Eisai
  • Andrew Sinclair-Pearson, Head of eMedia, Novartis
  • Stefan Flueckiger, New Media Manager, Bayer
  • Amanda Callaghan, Director of Communications, Association of the British Pharmaceutical Industry
  • Charmaine Griffiths, Director for Multimedia, British Heart Foundation

The conference is the premier event of its kind in Europe and the only event to focus exclusively on how social media can be used within the pharmaceutical industry and healthcare to foster patient-doctor interaction, knowledge of new treatments and also a greater understanding of various healthcare issues.

At no other event will you have access to such a wealth of experience, practical knowledge and expertise on how social media can be used to compliment and energize your communications activities!


Book now and learn, from the key figures in the industry, how to transform your social media strategies! Visit the website for more details:
www.pharma-social-media.com

Delegate Information

www.smi-online.co.uk/2011socialmedia24.asp

Quote Creation Healthcare and receive £200 off your delegate place.
Contact Mo Saffaf on tel +44 (0)20 7827 6022 or email: msaffaf@smi-online.co.uk

For more information about the Social Media in the Pharmaceutical Industry Conferenceclick here.

Through truly impartial advice about strategy and implementation, Creation Healthcare helps organisations develop initiatives which are aligned with business goals, and which deliver return on investment.